2017-04-22
The need for active surveillance for low risk prostate cancer
Publication
Publication
Additional Metadata | |
---|---|
, , , , , , , , | |
doi.org/10.1080/14737140.2017.1319767, hdl.handle.net/1765/99434 | |
Expert Review of Anticancer Therapy | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Drost, F.-J., & Roobol-Bouts, M. (2017). The need for active surveillance for low risk prostate cancer. Expert Review of Anticancer Therapy, 1–3. doi:10.1080/14737140.2017.1319767 |